These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19403721)

  • 1. The intention to treat principle, and the potential impact of excluding data from the analysis of clinical trial data.
    Sempos CT; Picciano MF
    J Nutr; 2009 Jun; 139(6):1204; author reply 1205-6. PubMed ID: 19403721
    [No Abstract]   [Full Text] [Related]  

  • 2. Inclusion of patients in clinical trial analysis: the intention-to-treat principle.
    Heritier SR; Gebski VJ; Keech AC
    Med J Aust; 2003 Oct; 179(8):438-40. PubMed ID: 14558871
    [No Abstract]   [Full Text] [Related]  

  • 3. Intention-to-treat analysis: protecting the integrity of randomization.
    Mahaniah KJ; Rao G
    J Fam Pract; 2004 Aug; 53(8):644. PubMed ID: 15298838
    [No Abstract]   [Full Text] [Related]  

  • 4. Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis.
    Fergusson D; Aaron SD; Guyatt G; Hébert P
    BMJ; 2002 Sep; 325(7365):652-4. PubMed ID: 12242181
    [No Abstract]   [Full Text] [Related]  

  • 5. Statistical Controversies in Reporting of Clinical Trials: Part 2 of a 4-Part Series on Statistics for Clinical Trials.
    Pocock SJ; McMurray JJV; Collier TJ
    J Am Coll Cardiol; 2015 Dec; 66(23):2648-2662. PubMed ID: 26670066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trend toward noninferiority trials may mean more difficult interpretation of trial results.
    Tuma RS
    J Natl Cancer Inst; 2007 Dec; 99(23):1746-8. PubMed ID: 18042926
    [No Abstract]   [Full Text] [Related]  

  • 7. Drug compliance in therapeutic trials: a review.
    Boudes P
    Control Clin Trials; 1998 Jun; 19(3):257-68. PubMed ID: 9620809
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A probiotics trial on trial: the problem of timely detection of adverse advents in therapeutic trials.
    Giard RW
    J Clin Epidemiol; 2010 Apr; 63(4):347-9. PubMed ID: 19762211
    [No Abstract]   [Full Text] [Related]  

  • 9. Interpretation of clinical trial results.
    Practice Committee of American Society for Reproductive Medicine
    Fertil Steril; 2008 Nov; 90(5 Suppl):S114-20. PubMed ID: 19007606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical trial designs for testing of products for dentine hypersensitivity--a review.
    Gillam DG
    J West Soc Periodontol Periodontal Abstr; 1997; 45(2):37-46. PubMed ID: 9477867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choosing the right sample.
    Gill J
    Radiol Technol; 2010; 81(6):610-1. PubMed ID: 20606055
    [No Abstract]   [Full Text] [Related]  

  • 12. [Including or excluding data: intention-to-treat and completer analyses].
    Böhnke JR; Lutz W
    Psychother Psychosom Med Psychol; 2012 Nov; 62(11):429. PubMed ID: 23143830
    [No Abstract]   [Full Text] [Related]  

  • 13. Intention-to-treat analysis in cluster randomized trials with noncompliance.
    Jo B; Asparouhov T; Muthén BO
    Stat Med; 2008 Nov; 27(27):5565-77. PubMed ID: 18623608
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Data analysis issues for protocols with overlapping enrollment.
    Larntz K; Neaton JD; Wentworth DN; Yurik T
    Stat Med; 1996 Nov 15-30; 15(21-22):2445-53; discussion 2455-8. PubMed ID: 8931212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estimating the Risk of a Rare But Plausible Complication That Has Not Occurred After n Trials.
    Ho AM; Ho AK; Mizubuti GB; Dion PW
    Anesth Analg; 2018 Nov; 127(5):1259-1263. PubMed ID: 29878940
    [No Abstract]   [Full Text] [Related]  

  • 16. Intention-to-treat analysis: who is in? Who is out?
    Kruse RL; Alper BS; Reust C; Stevermer JJ; Shannon S; Williams RH
    J Fam Pract; 2002 Nov; 51(11):969-71. PubMed ID: 12485553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Good intentions and ICH-GCP: Trial conduct training needs to go beyond the ICH-GCP document and include the intention-to-treat principle.
    Browne LH; Graham PH
    Clin Trials; 2014 Dec; 11(6):629-34. PubMed ID: 25023199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical trials in progressive neurological diseases. Recruitment, enrollment, retention and compliance.
    Bedlack RS; Cudkowicz ME
    Front Neurol Neurosci; 2009; 25():144-151. PubMed ID: 19478515
    [No Abstract]   [Full Text] [Related]  

  • 19. [Intention-to-treat].
    Faller H
    Rehabilitation (Stuttg); 2004 Feb; 43(1):52-5. PubMed ID: 14963806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statistical methods for clinical trials.
    Bailey A; Crook A; Machin D
    Blood Rev; 1994 Jun; 8(2):105-12. PubMed ID: 7950475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.